SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001640334-16-000854
Filing Date
2016-03-22
Accepted
2016-03-21 18:31:33
Documents
49

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-1 2016-mar21-nmus_posam.htm POS AM 1549230
2 EX-23.1 ex-23_1.htm EX-23.1 2321
9 logo.jpg GRAPHIC 33296
  Complete submission text file 0001640334-16-000854.txt   4445365

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT nmus-20151231.xml EX-101.INS 497648
4 XBRL TAXONOMY EXTENSION SCHEMA nmus-20151231.xsd EX-101.SCH 47099
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nmus-20151231_cal.xml EX-101.CAL 38088
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nmus-20151231_def.xml EX-101.DEF 171568
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nmus-20151231_lab.xml EX-101.LAB 378024
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nmus-20151231_pre.xml EX-101.PRE 258741
Mailing Address 650 TOWN CENTER DRIVE, SUITE 1770 COSTA MESA CA 92626
Business Address 650 TOWN CENTER DRIVE, SUITE 1770 COSTA MESA CA 92626 (949) 396-0330
Nemus Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-206992 | Film No.: 161519617
SIC: 2834 Pharmaceutical Preparations